This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1989:76:149-56; discussion 156-8.

doi: 10.1159/000417891.

Variations of recombinant human erythropoietin application in hemodialysis patients

J Bommer¹, W Samtleben, K M Koch, C A Baldamus, P Grützmacher, P Scigalla

Affiliations

PMID: 2684517
DOI: 10.1159/000417891

Clinical Trial

Variations of recombinant human erythropoietin application in hemodialysis patients

J Bommer et al. Contrib Nephrol. 1989.

. 1989:76:149-56; discussion 156-8.

doi: 10.1159/000417891.

Authors

J Bommer¹, W Samtleben, K M Koch, C A Baldamus, P Grützmacher, P Scigalla

Affiliation

¹ Nephrology Division, I. Medizinische Universitätsklinik, Heidelberg, FRG.

PMID: 2684517
DOI: 10.1159/000417891

No abstract available

PubMed Disclaimer

Similar articles

Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT. Sobota JT. Contrib Nephrol. 1989;76:166-78; discussion 212-8. Contrib Nephrol. 1989. PMID: 2684519 Clinical Trial. No abstract available.
Experience with daily self-administered subcutaneous erythropoietin.
Granolleras C, Branger B, Beau MC, Deschodt G, Alsabadani B, Shaldon S. Granolleras C, et al. Contrib Nephrol. 1989;76:143-7; discussion 147-8. doi: 10.1159/000417890. Contrib Nephrol. 1989. PMID: 2684516 Clinical Trial. No abstract available.
Efficacy comparison of intravenous and subcutaneous recombinant human erythropoietin administration in hemodialysis patients.
Bommer J, Barth HP, Zeier M, Mandelbaum A, Bommer G, Ritz E, Reichel H, Novack R. Bommer J, et al. Contrib Nephrol. 1991;88:136-43. doi: 10.1159/000419523. Contrib Nephrol. 1991. PMID: 2040175 No abstract available.
Erythropoietin therapy in chronic uremia: the impact of normalization of hematocrit.
Murphy ST, Parfrey PS. Murphy ST, et al. Curr Opin Nephrol Hypertens. 1999 Sep;8(5):573-8. doi: 10.1097/00041552-199909000-00007. Curr Opin Nephrol Hypertens. 1999. PMID: 10541220 Review.
Meeting the challenges of a new millennium: optimizing the use of recombinant human erythropoietin.
Macdougall IC. Macdougall IC. Nephrol Dial Transplant. 1998;13 Suppl 2:23-7. doi: 10.1093/ndt/13.suppl_2.23. Nephrol Dial Transplant. 1998. PMID: 9566487 Review.

See all similar articles

Cited by

Controversies in selection of epoetin dosages. Issues and answers.
Zachée P. Zachée P. Drugs. 1995 Apr;49(4):536-47. doi: 10.2165/00003495-199549040-00004. Drugs. 1995. PMID: 7789287 Review.
Assessment of pain after subcutaneous injection of erythropoietin in patients receiving haemodialysis.
Frenken LA, van Lier HJ, Gerlag PG, den Hartog M, Koene RA. Frenken LA, et al. BMJ. 1991 Aug 3;303(6797):288. doi: 10.1136/bmj.303.6797.288. BMJ. 1991. PMID: 1888931 Free PMC article. Clinical Trial. No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- S. Karger AG, Basel, Switzerland
Medical
- MedlinePlus Health Information